Jacobson Mark L. (CIK 1805812) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-05). Recent activity: Buy AXSM (4,517 shares), Sell AXSM (4,517 shares), Buy AXSM (233 shares), Sell AXSM (233 shares), Buy AXSM (35,378 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 4,517 | $58,495 |
| 2026-05-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 4,517 | $1.0M |
| 2026-05-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 233 | $3,017 |
| 2026-05-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 233 | $53,166 |
| 2026-02-27 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 35,378 | $100,827 |
| 2026-02-27 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 35,378 | $5.7M |
| 2025-09-22 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 10,000 | $28,500 |
| 2025-09-22 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 10,000 | $1.2M |
| 2025-09-17 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 5,783 | $671,927 |
| 2025-09-17 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 25,000 | $123,750 |
| 2025-09-17 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 15,000 | $72,750 |
| 2025-09-17 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 40,000 | $4.6M |
| 2025-06-10 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 25,000 | $200,500 |
| 2025-06-10 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 25,000 | $2.8M |
| 2025-05-28 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 20,673 | $133,754 |
| 2025-05-28 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 20,673 | $2.2M |
| 2025-05-28 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Buy | 20,000 | $129,400 |
| 2025-05-28 | Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Sell | 20,000 | $2.1M |
Source: SEC Form 4 filings · as of 2026-05-05